Exp Mol Med.  2014 Feb;46(2):e79. 10.1038/emm.2013.152.

MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes

Affiliations
  • 1Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. zhangyukun.com@hotmail.com

Abstract

Osteoarthritis is a common cause of functional deterioration in older adults and is an immense burden on the aging population. Altered chondrogenesis is the most important pathophysiological process involved in the development of osteoarthritis. However, the molecular mechanism underlying the regulation of chondrogenesis in patients with osteoarthritis requires further elucidation, particularly with respect to the role of microRNAs. MiR-21 expression in cartilage specimens was examined in 10 patients with knee osteoarthritis and 10 traumatic amputees. The effect of miR-21 on chondrogenesis was also investigated in a chondrocyte cell line. The effect of miR-21 on the expression of growth differentiation factor 5 (GDF-5) was further assessed by luciferase reporter assay and western blot. We found that endogenous miR-21 is upregulated in osteoarthritis patients, and overexpression of miR-21 could attenuate the process of chondrogenesis. Furthermore, we identified GDF-5 as the direct target of miR-21 during the regulation of chondrogenesis. Our data suggest that miR-21 has an important role in the pathogenesis of osteoarthritis and is a potential therapeutic target.

Keyword

chondrogenesis; GDF-5; miR-21; osteoarthritis

MeSH Terms

Cartilage/metabolism/pathology
Case-Control Studies
Cell Line
Chondrocytes/*metabolism/pathology
Growth Differentiation Factor 5/genetics/*metabolism
Humans
MicroRNAs/genetics/*metabolism
Osteoarthritis/*metabolism/pathology
Up-Regulation
Growth Differentiation Factor 5
MicroRNAs
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr